(E)-3-(1H-imidazol-2-yl)-1-(4-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)prop-2-en-1-one

ID: ALA4585640

Chembl Id: CHEMBL4585640

PubChem CID: 18782952

Max Phase: Preclinical

Molecular Formula: C17H18N2O3

Molecular Weight: 298.34

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(/C=C/c1ncc[nH]1)c1ccc(OC2CCCCO2)cc1

Standard InChI:  InChI=1S/C17H18N2O3/c20-15(8-9-16-18-10-11-19-16)13-4-6-14(7-5-13)22-17-3-1-2-12-21-17/h4-11,17H,1-3,12H2,(H,18,19)/b9-8+

Standard InChI Key:  PSPBCDJPGZTQAR-CMDGGOBGSA-N

Associated Targets(Human)

HBA1 Tclin Hemoglobin HbA (880 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 298.34Molecular Weight (Monoisotopic): 298.1317AlogP: 3.21#Rotatable Bonds: 5
Polar Surface Area: 64.21Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.71CX Basic pKa: 6.44CX LogP: 2.74CX LogD: 2.70
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.68Np Likeness Score: -0.18

References

1. Omar AM, David T, Pagare PP, Ghatge MS, Chen Q, Mehta A, Zhang Y, Abdulmalik O, Naghi AH, El-Araby ME, Safo MK..  (2019)  Structural modification of azolylacryloyl derivatives yields a novel class of covalent modifiers of hemoglobin as potential antisickling agents.,  10  (11): [PMID:32206236] [10.1039/C9MD00291J]

Source